Infection and Immunity
Infectious diseases are among the greatest global health challenges as shown by recent and past pandemics.
Human activities, including urban expansion, intensive farming, and increased global travel, have accelerated the emergence and spread of new infectious diseases. At the same time the growing problem of antimicrobial resistance, is making once-reliable treatments less effective.
Research at LIMS focuses on advancing our understanding of infection processes, improving early detection and monitoring of infections. With the goal of developing novel methods for their prevention and treatment, all with a personalised medicine and health equity lens. Infection and Immunity research explores how the body responds to infections and immune system disorders, with the goal of fine-tuning these responses to improve health.
By understanding the immune mechanisms that drive diseases such as cancer, diabetes, and cardiovascular conditions. LIMS researchers aim to develop targeted therapies that restore balance and prevent harmful inflammation. LIMS is at the forefront of discovering how immune modulation can transform treatment across a wide range of chronic and infectious diseases.